Skip to main content

Immunotherapy (Checkpoint Inhibitor)

28 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Immunotherapy (Checkpoint Inhibitor) (16)

Clear all filters
Clear all filters

Sintilimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Tislelizumab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Toripalimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Zimberelimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb